Skip to content
Featured on Startup Fame

Mumbai’s Health Reactive India makes Ayurvedic formulation to support cancer patients

Health Reactive India, a Mumbai-based company founded in 1996, manufactures Body Revival®, an Ayurvedic formulation designed to complement cancer treatment. The product targets patients undergoing chemotherapy, aiming to alleviate side effects like fatigue, nausea, and appetite loss. According to YourStory, the company’s clinical trial is registered with India’s official trial registry.

Editor, Lazyfounder

Published Updated 2 min read

What Health Reactive India does

Health Reactive India, based in Mumbai, manufactures Body Revival®, an Ayurvedic formulation designed to support cancer patients undergoing chemotherapy. According to YourStory, the product is clinically researched and aims to help manage side effects such as fatigue, nausea, and appetite loss. It is marketed as a complementary treatment, not a replacement for oncology care.

The company was founded in 1996 and operates on a business-to-consumer (B2C) model. It also sells its product to oncologists, targeting small enterprises in the healthcare sector. Body Revival® is available to patients across income groups, from lower to high income, and is shipped pan-India.

Health Reactive India’s clinical trial for Body Revival® is registered with the Clinical Trial Registry of India (CTRI), a transparency standard that, according to the source, most Ayurvedic brands do not meet.

Why this matters for founders and operators

The company’s focus on a clinically validated Ayurvedic product highlights a growing segment in India’s health and wellness market: evidence-backed complementary therapies. For founders in the healthtech, medtech, or Ayurveda space, this signals demand for products that bridge traditional medicine with modern clinical standards.

Its dual sales model—direct-to-consumer and through oncologists—demonstrates a strategy to build trust with both patients and medical professionals. This approach may offer lessons for startups navigating regulatory scrutiny or targeting niche healthcare needs.

Registration with CTRI also sets a benchmark for transparency in Ayurvedic product development, which could influence how competitors or new entrants design their clinical validation processes.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

Health Reactive India’s work underscores the potential for Ayurvedic products to gain credibility in mainstream healthcare, provided they meet clinical and regulatory standards. For founders, this is a case study in how traditional systems can be positioned alongside modern medicine—not as alternatives, but as complementary solutions. The company’s focus on oncology, a high-stakes medical field, also shows that even niche segments can be addressed with the right validation and messaging.

Sources

  1. yourstory.com
    Health Reactive India Company Profile Funding & Investors

This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.

About the author

Editor, Lazyfounder

Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.

More stories by Tarun Mottlia

Get the LazyFounder Brief

Startup, funding and AI news in a five-minute read. Join the early-access list.

Lazy Founder - Powered by Blogy.in

Contact us

Have a story tip, correction or partnership idea?

Write to us at tarun.kumar@blogy.in or talk to the founder directly. We read every message.

Contact us